Call Us

Hamzavi Dermatology Clinical Trials

Get Paid To Participate in Dermatology Clinical Trials

We are currently enrolling patients in investigational treatment trials for Psoriasis, Vitiligo & Hidradenitis Suppurativa

Call us at 810-455-1612 for more information.

Email Us

Clinical trials are conducted for the development of drugs and treatment of conditions. They are important to learning the effectiveness of a drug or treatment, and potential side effects. For further information on clinical trials, please refer to www.ClinicalTrials.gov.

Psoriasis



Observational

Get Paid $25/each completed visit

Visits every 6 months

Psoriasis

Observational

Get Paid $25/each completed visit

Visits every 6 months

Hidradenitis Suppurativa

Investigational Medication

Get Paid To Participate

≥ 18 yrs

Approximately 54 weeks/15 office visits

Vitiligo

Vitiligo


Investigational Medication

Get Paid To Participate

≥ 18 yrs

Approximately 52 weeks/11 office visits

Participate 

If you, or someone you know, is interested in participating in a Clinical Trial please contact us by phone 810-455-1612, by email clinicaltrials@hamzavi.com, or by filling out the form below to see if you qualify today!

Please note, you do not have to be a patient of our practice in order to be considered for any study.

Contact Us

Our Team 

  • Dr. Fasahat Hamzavi, MD, Director of Clinical Trials, Principal Investigator in Fort Gratiot
  • Dr. Iltefat Hamzavi, MD, Principal Investigator in Canton
  • Dr. Nastassja Bedford-Lyon, Sub-Investigator in Fort Gratiot
  • Dr. Marsha Henderson, MD Sub-Investigator in Canton
  • Dr. Chelsea Luther, MD, Principal Investigator in Canton
  • Lee Campbell, BSN, RN, CCRC, Clinical Site Manager
  • Alyson Campbell, NCMA, CCRC, Study Coordinator
  • Brynn Bemis, RN, Study Coordinator
  • Camrynn Collinge, Study Coordinator

Clinical Study Process 

1.

INTERESTED IN A CLINICAL STUDY?

We will set an appointment

with you over the phone.

2.

FIRST APPOINTMENT

We will confirm your eligibility through a clinical evaluation and explain the study

3.

YOU ARE ELIGIBLE TO PARTICIPATE

The decision to participate in the study is up to you and you must sign an informed consent form.

request-appointmnet

4.

PARTICIPATION IN THE STUDY

We will set an appointment

with you over the phone.You attend the appointments scheduled according to the study calendar.

5.

COMPENSATION

At the end of the study patient compensation is provided.

FAQ 

  • Who can participate in clinical trials?

    Researchers consider several factors such as gender, age, type and stage of disease, previous medical history and treatment of condition. Some studies require healthy individuals and some require the participant to have the illness or condition. Before enrolling, a patient must qualify for the study.

  • Why do people participate?

    People participate in clinical trials for several reasons. Some participate in order to receive advanced treatment while others want to assist the doctors and scientists. It would be difficult for the study to complete the discovery of a new drug without the participation of subjects and their interests and patience.

  • What do I need to know if I am participating in clinical trials?

    Patients must offer informed consent to participate. In order to offer this consent, patients should learn the key facts in the clinical trial. They should know the details of the study such as purpose, safety, duration, side effects and required procedure(s). Patients should know that they have the right to withdraw from any study at any time.

  • What questions should I ask if I am participating in the clinical trials?

    Patients should ask questions and discuss their concerns with the doctors and the study coordinators. Patients should know the purpose and duration of the study as well as the tests and investigational treatment(s) involved.


    For further questions, please email our research staff at clinicaltrials@hamzavi.com.

  • How does Good Clinical Practice (GCP) protect participants?

    A standard for the design, conduct, performance, monitoring, auditing, recording, analyses and reporting of clinical trials that provides assurance that the data and reported results are credible and accurate, and that the rights, integrity and confidentiality of trial subjects are protected.

  • What happens when the clinical trial is completed?

    After successful phases are completed, the researchers look at the study, decide if it has clinical importance and inform the medical community. To learn the results of the studies in which you participated, ask the doctor or nurse in charge of your treatment.